Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Change in Intangibles (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Change in Intangibles for 3 consecutive years, with $300000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Change in Intangibles fell 57.14% to $300000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $300000.0, a 57.08% decrease, with the full-year FY2024 number at $699000.0, up 66.83% from a year prior.
  • Change in Intangibles was $300000.0 for Q1 2025 at Mereo BioPharma, up from -$1000.0 in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of $700000.0 in Q1 2024 to a low of -$1000.0 in Q2 2024.
  • A 3-year average of $354500.0 and a median of $359500.0 in 2023 define the central range for Change in Intangibles.
  • Peak YoY movement for Change in Intangibles: skyrocketed 67.06% in 2024, then plummeted 57.14% in 2025.
  • Mereo BioPharma's Change in Intangibles stood at $419000.0 in 2023, then tumbled by 100.24% to -$1000.0 in 2024, then surged by 30100.0% to $300000.0 in 2025.
  • Per Business Quant, the three most recent readings for MREO's Change in Intangibles are $300000.0 (Q1 2025), -$1000.0 (Q2 2024), and $700000.0 (Q1 2024).